博腾股份(300363) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥1,377,802,786.78, a decrease of 4.50% compared to ¥1,442,770,395.49 in the same period last year[3] - Net profit attributable to shareholders was ¥304,092,146.15, down 20.37% from ¥381,898,709.67 year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥296,262,380.67, reflecting a decline of 22.24% compared to ¥381,009,392.25 in the previous year[3] - Basic and diluted earnings per share were both ¥0.56, down 20.00% from ¥0.70 in the previous year[3] - In Q1 2023, the company achieved total revenue of 1.378 billion yuan, a year-on-year decrease of approximately 5% due to the delivery of significant orders received in previous periods[16] - The net profit attributable to shareholders was 358 million yuan, down about 14% year-on-year, primarily due to losses from emerging businesses[16] Cash Flow and Operating Activities - The company's cash flow from operating activities increased by 8.68% to ¥363,297,371.75 from ¥334,267,821.88 in the same period last year[3] - In Q1 2023, the company received cash related to operating activities amounting to ¥167,052,654.12, a significant increase of 539.25% compared to ¥26,132,511.55 in Q1 2022, primarily due to an increase in the recovery of deposit guarantees[9] - The cash paid for purchasing goods and services was ¥803,815,554.48, reflecting a 49.24% increase from ¥538,622,704.50 in the same period last year, attributed to higher procurement payments[9] - Cash paid for other operating activities decreased by 40.26% to ¥77,319,398.81 from ¥129,436,828.59, mainly due to a reduction in deposit guarantees paid[9] - Total cash inflow from operating activities reached CNY 1,698,129,800.41, compared to CNY 1,395,007,604.29 in the same period last year, indicating a year-over-year increase of about 21.7%[30] Assets and Liabilities - The total assets at the end of Q1 2023 were ¥10,023,735,617.15, a decrease of 1.19% from ¥10,144,292,774.55 at the end of the previous year[3] - Total liabilities decreased to CNY 3,240,995,132.55 from CNY 3,672,000,486.45, a reduction of 11.7%[25] - Non-current liabilities increased to CNY 911,552,118.09 from CNY 656,007,317.81, an increase of 38.8%[25] - The company's total equity rose to CNY 6,782,740,484.60, up from CNY 6,472,292,288.10, indicating a growth of 4.8%[25] Research and Development - Research and development expenses rose by 58.20% to ¥165,970,275.02, driven by an increase in R&D personnel and ongoing investments in technology platforms[8] - Research and development expenses increased to CNY 165,970,275.02, up 58% from CNY 104,914,096.80 in Q1 2022[26] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 62,971[11] - The largest shareholder, Chongqing Liangjiang New Area Industrial Development Group Co., Ltd., holds 14.46% of the shares, totaling 78,982,719 shares[11] Strategic Investments - The company’s strategic investments included the acquisition of 100% equity in Kaihui Pharmaceutical (Shanghai) Co., Ltd[16] Employee and Operational Metrics - The company’s employee count rose to 5,377, a 29% increase compared to the same period last year[16] - The company reported a total of 299 signed customer orders, representing a year-on-year growth of approximately 30%[16] - The number of single customers increased to 37, marking a year-on-year growth of 68%[16] Tax and Government Subsidies - The company received government subsidies amounting to ¥10,058,624.94, an increase of 263.12% compared to ¥2,770,023.02 in the previous year[8] - The company reported a significant increase in tax expenses, with a decrease in profit leading to a tax expense of ¥38,052,887.60, down 36.02% from ¥59,477,591.43 in the previous year[8] - The company received CNY 79,897,199.77 in tax refunds, compared to CNY 98,430,190.82 in the previous year, reflecting a decrease of approximately 18.5%[30] Cash and Financing Activities - Cash received from borrowings was ¥159,806,540.09, a decrease of 71.42% compared to ¥559,126,133.95, primarily due to reduced bank borrowings[9] - Cash paid for debt repayment was ¥127,298,000.00, down 59.50% from ¥314,350,305.64, reflecting a decrease in bank loan repayments[9] - The company distributed dividends and interest payments totaling ¥5,086,369.72, a decrease of 67.49% from ¥15,644,093.33, attributed to lower interest payments[9] - The net cash flow from financing activities was CNY 32,743,083.39, down from CNY 255,142,167.21 in Q1 2022, indicating a decrease of approximately 87.2%[30] Audit Information - The company did not conduct an audit for the Q1 2023 report[31]